Key Takeaways
- Elon Musk revealed the Terafab initiative begins in 7 days, establishing a semiconductor production plant at Tesla’s Austin Gigafactory campus
- The plant aims to prevent a semiconductor shortage that Musk predicts could constrain Tesla’s expansion within 3–4 years
- Tesla’s ambitious Optimus humanoid robot vision may demand 200 million+ semiconductors annually — a 50-fold increase over present requirements
- Morgan Stanley’s Andrew Percoco projects the fabrication plant could require $35B–$40B investment with chip output starting around 2028
- Musk emphasized geopolitical vulnerabilities as a primary motivation for establishing domestic semiconductor production capabilities
Shares of Tesla advanced 0.6% during early Wednesday market activity to reach $401.75, following CEO Elon Musk’s announcement that the electric vehicle manufacturer’s “Terafab” semiconductor production facility will commence operations on March 21 at the company’s Austin, Texas manufacturing complex.
Musk initially teased this initiative during a January 2026 conference call with investors, then disclosed the Austin site selection through a March 14 social media post on X. The semiconductor facility will be integrated into Tesla’s expansive 2,500-acre Gigafactory Texas property.
The fundamental rationale is straightforward: Musk anticipates Tesla facing a semiconductor supply crisis. “When I look ahead and say what’s the limiting factor for Tesla growth, if you go 3 or 4 years out, I think it actually is chip production,” he explained to investors during the January call.
He further identified memory and AI computational capacity as additional potential constraints. “Is there enough AI logic and enough memory, enough RAM for our volume?” Musk questioned during the discussion.
The Strategic Rationale Behind Tesla’s Chip Manufacturing Push
Morgan Stanley’s Andrew Percoco analyzed the figures. Should Tesla achieve its ambitious long-term vision of producing 100 million-plus Optimus humanoid robots yearly, the company would require over 200 million semiconductors each year. This represents more than a 50-fold multiplication of Tesla’s present chip consumption across its vehicle and robotaxi divisions.
Percoco noted that Tesla’s strategic move toward in-house chip manufacturing stems from dual concerns: geopolitical vulnerabilities and the Optimus initiative. Company leadership warned that AI computational power could become a critical limitation within three to four years.
Musk spoke candidly regarding geopolitical considerations. He emphasized the Terafab must encompass “logic, memory and packaging domestically” to mitigate supply chain vulnerabilities. “I think people may be underweighting some of the geopolitical risks,” he stated.
Constructing a fabrication facility demands substantial capital and time. As a comparison, Micron’s memory chip production facility in Boise commenced construction in 2022 and isn’t projected to manufacture chips until 2027.
Financial Investment and Project Magnitude
Percoco projects Tesla may encounter expenditures between $35 billion and $40 billion to develop its proprietary chip fabrication capabilities. Under even favorable conditions, he anticipates chip production wouldn’t begin until 2028.
This represents a significant departure from Tesla’s conventional capital allocation patterns. The company typically allocates less than $10 billion annually toward manufacturing facilities and machinery, although it has indicated plans to invest $20 billion during 2026 to support its expanding robotics operations.
Percoco characterized the fabrication plant as a “Herculean task” and suggested Tesla might alternatively pursue partnerships with established semiconductor manufacturers instead of building independently. He maintains a Hold rating on Tesla stock with a $415 price objective.
Tesla shares entered Wednesday’s trading session showing an 11% decline year-to-date while posting a 77% gain over the trailing 12 months. Both S&P 500 and Dow Jones futures exhibited modest gains during the trading day.
The Terafab facility is scheduled to officially commence operations on March 21.


